This study is being conducted to determine the clinical safety and efficacy of Pro-2-Cool mediated head and neck cooling when applied after concussion and improved symptomatology among adolescent athletes as quantified by post-concussion symptom severity (PCSS) score.
This is a multi-center, prospective, randomized, double-blinded, dual-arm comparative study enrolling up to a total of 66 patients (approximately 33 patients in the treatment arm and 33 patients in the control arm) following sports-related, concussion.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
66
The Pro2Cool Device is a non-invasive hypothermic therapy ("cold therapy") device that provides localized cooling of the head and neck. Water and isopropyl alcohol cooled to 6°C by the chiller assembly circulate through the cooling garment to create conductive heat transfer from the scalp and carotid arteries, thus achieving cooling of the brain.
The sham cooling garment device will be placed with impaired cooling function (only to the head), with sham treatment temperature being set to 19°C (instead of the therapeutic 6°C specification). There will be no thermal nylon barrier that will be used and flow to the neck bladder will be closed.
University of Michigan
Ann Arbor, Michigan, United States
RECRUITINGAkron Children's Hospital
Akron, Ohio, United States
RECRUITINGCleveland Clinic Foundation
Cleveland, Ohio, United States
NOT_YET_RECRUITINGChange quantified by post-concussion symptom severity (PCSS) assessment score
Time frame: Post-injury to 72-hour follow-up
Number of adverse events associated with the head-and-neck cooling treatment
Time frame: Treatment to 72-hour follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.